Chirehwa M - Search Results

1

Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis.

Abdelgawad N, Chirehwa M, Schutz C, Barr D, Ward A, Janssen S, Burton R, Wilkinson RJ, Shey M, Wiesner L, McIlleron H, Maartens G, Meintjes G, Denti P. Abdelgawad N, et al. Among authors: chirehwa m. Wellcome Open Res. 2024 Mar 1;7:72. doi: 10.12688/wellcomeopenres.17660.3. eCollection 2022. Wellcome Open Res. 2024. PMID: 37008250 Free PMC article.

2

Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction.

Chirehwa MT, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, McIlleron H, Denti P. Chirehwa MT, et al. Antimicrob Agents Chemother. 2015 Nov 9;60(1):487-94. doi: 10.1128/AAC.01830-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26552972 Free PMC article.

3

Erratum for Chirehwa et al., Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction.

Chirehwa MT, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, McIlleron H, Denti P. Chirehwa MT, et al. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3262. doi: 10.1128/AAC.00483-16. Print 2016 May. Antimicrob Agents Chemother. 2016. PMID: 27107106 Free PMC article. No abstract available.

4

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients.

Rockwood N, Meintjes G, Chirehwa M, Wiesner L, McIlleron H, Wilkinson RJ, Denti P. Rockwood N, et al. Among authors: chirehwa m. Antimicrob Agents Chemother. 2016 Sep 23;60(10):6050-9. doi: 10.1128/AAC.00480-16. Print 2016 Oct. Antimicrob Agents Chemother. 2016. PMID: 27480859 Free PMC article.

5

Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.

Naidoo A, Chirehwa M, McIlleron H, Naidoo K, Essack S, Yende-Zuma N, Kimba-Phongi E, Adamson J, Govender K, Padayatchi N, Denti P. Naidoo A, et al. Among authors: chirehwa m. J Antimicrob Chemother. 2017 May 1;72(5):1441-1449. doi: 10.1093/jac/dkx004. J Antimicrob Chemother. 2017. PMID: 28175315 Free PMC article. Clinical Trial.

6

Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.

Chirehwa MT, McIlleron H, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, Denti P. Chirehwa MT, et al. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00490-17. doi: 10.1128/AAC.00490-17. Print 2017 Aug. Antimicrob Agents Chemother. 2017. PMID: 28607022 Free PMC article.

7

Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis.

Naidoo A, Ramsuran V, Chirehwa M, Denti P, McIlleron H, Naidoo K, Yende-Zuma N, Singh R, Ngcapu S, Chaudhry M, Pepper MS, Padayatchi N. Naidoo A, et al. Among authors: chirehwa m. Pharmacogenomics. 2018 Jan;19(1):17-29. doi: 10.2217/pgs-2017-0144. Epub 2017 Dec 6. Pharmacogenomics. 2018. PMID: 29210323 Free PMC article.

8

Quality assurance of rifampicin-containing fixed-drug combinations in South Africa: dosing implications.

Court R, Chirehwa MT, Wiesner L, Wright B, Smythe W, Kramer N, McIlleron H. Court R, et al. Among authors: chirehwa mt. Int J Tuberc Lung Dis. 2018 May 1;22(5):537-543. doi: 10.5588/ijtld.17.0697. Int J Tuberc Lung Dis. 2018. PMID: 29663959 Free PMC article. Clinical Trial.

9

Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis.

Court RG, Wiesner L, Chirehwa MT, Stewart A, de Vries N, Harding J, Gumbo T, McIlleron H, Maartens G. Court RG, et al. Among authors: chirehwa mt. Int J Tuberc Lung Dis. 2018 Aug 1;22(8):926-930. doi: 10.5588/ijtld.18.0091. Int J Tuberc Lung Dis. 2018. PMID: 29991403 Free PMC article. Clinical Trial.

10

Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazid.

Chirehwa MT, McIlleron H, Wiesner L, Affolabi D, Bah-Sow O, Merle C, Denti P; RAFA team. Chirehwa MT, et al. J Antimicrob Chemother. 2019 Jan 1;74(1):139-148. doi: 10.1093/jac/dky378. J Antimicrob Chemother. 2019. PMID: 30239829 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters